Propanc Biopharma, Inc. (PPCB)
NASDAQ·Healthcare·Biotechnology
$0.10
+0.39%
Mkt Cap $2.68M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | — | — | — | — | -$0.30 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | — | -$0.39 | — | — | — |
| Q3 2025 Sep 29, 2025 | — | $29.90K | — | — | -$0.35 | — | — | — |
| Q2 2025 May 15, 2025 | — | — | — | — | -$12.50 | — | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | — | -$32.23 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$287.82 | — | — | — |
| Q3 2024 Sep 30, 2024 | — | — | — | — | -$253.05 | — | — | — |
| Q2 2024 May 15, 2024 | — | — | — | — | -$625.00 | — | — | — |
| Q1 2024 Feb 20, 2024 | — | — | — | — | -$1875.00 | — | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | — | -$2500.00 | — | — | — |
| Q3 2023 Sep 28, 2023 | — | — | — | — | -$0.12 | — | — | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$0.42 | — | — | — |
| Q1 2023 Feb 9, 2023 | — | — | — | — | -$0.51 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | — | -$1.30 | — | — | — |
| Q3 2022 Sep 28, 2022 | — | — | — | — | -$4.11 | — | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$625000.00 | — | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | — | -$1250000.00 | — | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | — | -$1250000.00 | — | — | — |
| Q3 2021 Sep 28, 2021 | — | — | — | — | -$55.43 | — | — | — |
| Q2 2021 May 14, 2021 | — | — | — | — | -$7500000.00 | — | — | — |